|dcterms.references||1 WHO. The World Health Report 2000—health systems: improving
performance. Geneva: World Health Organization, 2000.
2 WHO. Everybody’s business: strengthening health systems to
improve health outcomes: WHO’s framework for action. Geneva:
World Health Organization, 2007.
3 WHO. Declaration of Alma-Ata. Almaty: World Health Organization,
4 UN. Transforming our world: the 2030 Agenda for Sustainable
Development. New York: United Nations, 2015.
5 WHO. The World Health Report 2010—health systems financing:
the path to universal coverage. Geneva: World Health Organization,
6 Nolte E, McKee M. Does health care save lives? Avoidable mortality
revisited. London: The Nuffield Trust, 2004.
7 Nolte E, McKee M. Measuring the health of nations: analysis of
mortality amenable to health care. BMJ 2003; 327: 1129.
8 Nolte E, McKee CM. Measuring the health of nations: updating an
earlier analysis. Health Aff (Millwood) 2008; 27: 58–71.
9 Nolte E, McKee M. Variations in amenable mortality—trends in
16 high-income nations. Health Policy 2011; 103: 47–52.
10 Mackenbach JP, Hoffmann R, Khoshaba B, et al. Using ‘amenable
mortality’ as indicator of healthcare effectiveness in international
comparisons: results of a validation study.
J Epidemiol Community Health 2013; 67: 139–46.
11 Eurostat. Amenable and preventable deaths statistics. 2017.
Amenable_and_preventable_deaths_statistics (accessed Jan 28, 2018).
12 Gay JG, Paris V, Devaux M, de Looper M. Mortality amenable to
health care in 31 OECD countries. Paris: Organisation for Economic
Co-operation and Development, 2011.
13 Radley DC, McCarthy D, Lippa JA, Hayes SL, Schoen C. Aiming
higher: results from a scorecard on state health system performance,
2014. Washington, DC: The Commonwealth Fund, 2014.
14 Hone T, Rasella D, Barreto M, Atun R, Majeed A, Millett C. Large
reductions in amenable mortality associated with Brazil’s primary
care expansion and strong health governance. Health Aff (Millwood)
2017; 36: 149–58.
15 Mackenbach JP, Hu Y, Artnik B, et al. Trends in inequalities in
mortality amenable to health care in 17 European countries.
Health Aff (Millwood) 2017; 36: 1110–18.
16 Schmidt H, Gostin LO, Emanuel EJ. Public health, universal health
coverage, and Sustainable Development Goals: can they coexist?
Lancet 2015; 386: 928–30.
17 Weber A, Clerc M. Deaths amenable to health care: Converging
trends in the EU? Health Policy 2017; 121: 644–52.
18 Gusmano MK, Rodwin VG, Wang C, Weisz D, Luo L, Hua F.
Shanghai rising: health improvements as measured by avoidable
mortality since 2000. Int J Health Policy Manag 2014; 4: 7–12.
19 Franco-Marina F, Lozano R, Villa B, Soliz P. La Mortalidad en
México, 2000–2004: Muertes Evitables: magnitud, distribución y
tendencias. México: Dirección General de Información en Salud,
Secretaría de Salud, 2006.
20 Barber RM, Fullman N, Sorensen RJD, et al. Healthcare Access and
Quality Index based on mortality from causes amenable to personal
health care in 195 countries and territories, 1990–2015: a novel
analysis from the Global Burden of Disease Study 2015. Lancet 2017;
21 Kruk ME, Kelley E, Syed SB, Tarp F, Addison T, Akachi Y.
Measuring quality of health-care services: what is known and where
are the gaps? Bull World Health Organ 2017; 95: 389.
22 Sunkara V, Hébert JR. The colorectal cancer mortality-to-incidence
ratio as an indicator of global cancer screening and care. Cancer
2015; 121: 1563–69.
23 Mokdad AH, Ballestros K, Echko M, et al. The state of US health,
1990–2016: burden of diseases, injuries, and risk factors among US
states. JAMA 2018; 319: 1444–72.
24 Dandona L, Dandona R, Kumar GA, et al. Nations within a nation:
variations in epidemiological transition across the states of India,
1990–2016 in the Global Burden of Disease Study. Lancet 2017;
25 ICMR, PHFI, IHME. India: Health of the Nation’s States—
The India State-Level Disease Burden Initiative. New Dehli: Indian
Council of Medical Research, Public Health Foundation of India,
Institute for Health Metrics and Evaluation, 2017.
26 de Souza MdeFM, França EB, Cavalcante A. Burden of disease and
health situation analysis: results of the Global Burden of Disease
(GBD) Brazil network. Rev Bras Epidemiol 2017; 20: 1–3.
27 Nomura S, Sakamoto H, Glenn S, et al. Population health and
regional variations of disease burden in Japan, 1990–2015:
a systematic subnational analysis for the Global Burden of Disease
Study 2015. Lancet 2017; 390: 1521–38.
28 Gómez-Dantés H, Fullman N, Lamadrid-Figueroa H, et al.
Dissonant health transition in the states of Mexico, 1990–2013:
a systematic analysis for the Global Burden of Disease Study 2013.
Lancet 2016; 388: 2386–402.
29 Zhou M, Wang H, Zhu J, et al. Cause-specific mortality for 240 causes
in China during 1990–2013: a systematic subnational analysis for the
Global Burden of Disease Study 2013. Lancet 2016; 387: 251–72.
30 Newton JN, Briggs ADM, Murray CJL, et al. Changes in health in
England, with analysis by English regions and areas of deprivation,
1990–2013: a systematic analysis for the Global Burden of Disease
Study 2013. Lancet 2015; 386: 2257–74.
31 Naghavi M, Abajobir AA, Abbafati C, et al. Global, regional,
and national age-sex specific mortality for 264 causes of death,
1980–2016: a systematic analysis for the Global Burden of Disease
Study 2016. Lancet 2017; 390: 1151–210.
32 Gakidou E, Afshin A, Abajobir AA, et al. Global, regional,
and national comparative risk assessment of 84 behavioural,
environmental and occupational, and metabolic risks or clusters of
risks, 1990–2016: a systematic analysis for the Global Burden of
Disease Study 2016. Lancet 2017; 390: 1345–422.
33 Vos T, Abajobir AA, Abate KH, et al. Global, regional, and national
incidence, prevalence, and years lived with disability for 328 diseases
and injuries for 195 countries, 1990–2016: a systematic analysis for
the Global Burden of Disease Study 2016. Lancet 2017; 390: 1211–59.
34 Stevens GA, Alkema L, Black RE, et al. Guidelines for Accurate and
Transparent Health Estimates Reporting: the GATHER statement.
Lancet 2016; 388: e19–23.
35 Asadzadeh Vostakolaei F, Karim-Kos HE, Janssen-Heijnen MLG,
Visser O, Verbeek ALM, Kiemeney LALM. The validity of the
mortality to incidence ratio as a proxy for site-specific cancer
survival. Eur J Public Health 2011; 21: 573–77.
36 Forouzanfar MH, Afshin A, Alexander LT, et al. Global, regional,
and national comparative risk assessment of 79 behavioural,
environmental and occupational, and metabolic risks or clusters of
risks, 1990–2015: a systematic analysis for the Global Burden of
Disease Study 2015. Lancet 2016; 388: 1659–724.
37 Wang H, Abajobir AA, Abate KH, et al. Global, regional, and
national under-5 mortality, adult mortality, age-specific mortality,
and life expectancy, 1970–2016: a systematic analysis for the Global
Burden of Disease Study 2016. Lancet 2017; 390: 1084–150.
38 Fullman N, Barber RM, Abajobir AA, et al. Measuring progress
and projecting attainment on the basis of past trends of the
health-related Sustainable Development Goals in 188 countries:
an analysis from the Global Burden of Disease Study 2016. Lancet
2017; 390: 1423–59.
39 Frenk J. The concept and measurement of accessibility. In: Health
services research: an anthology. White KL, Frenk J, Ordonez C,
Paganini JM, Starfield B, eds. Washington, DC: Pan American
Health Organization, 1992.
40 Dieleman JL, Haakenstad A, Micah A, et al. Spending on health and
HIV/AIDS: domestic health spending and development assistance
in 188 countries, 1995–2015. Lancet 2018; 391: 1799–829.
41 Wang H, Naghavi M, Allen C, et al. Global, regional, and national
life expectancy, all-cause mortality, and cause-specific mortality for
249 causes of death, 1980–2015: a systematic analysis for the Global
Burden of Disease Study 2015. Lancet 2016; 388: 1459–544.
42 Knaul FM, González-Pier E, Gómez-Dantés O, et al. The quest for
universal health coverage: achieving social protection for all in
Mexico. Lancet 2012; 380: 1259–79.
43 Lozano R, Soliz P, Gakidou E, et al. Benchmarking of performance
of Mexican states with effective coverage. Lancet 2006; 368: 1729–41.
44 Gutiérrez JP, García-Saisó S, Dolci GF, Ávila MH. Effective access
to health care in Mexico. BMC Health Serv Res 2014; 14: 186.
45 Desai M, Nolte E, Karanikolos M, Khoshaba B, McKee M.
Measuring NHS performance 1990–2009 using amenable mortality:
interpret with care. J R Soc Med 2011; 104: 370–79.
46 Watkins J, Wulaningsih W, Zhou CD, et al. Effects of health and
social care spending constraints on mortality in England: a time
trend analysis. BMJ Open 2017; 7: e017722.
47 Rice T, Unruh LY, Rosenau P, Barnes AJ, Saltman RB,
van Ginneken E. Challenges facing the United States of America
in implementing universal coverage. Bull World Health Organ
2014; 92: 894–902.
48 Hay SI, Abajobir AA, Abate KH, et al. Global, regional, and national
disability-adjusted life-years (DALYs) for 333 diseases and injuries
and healthy life expectancy (HALE) for 195 countries and territories,
1990–2016: a systematic analysis for the Global Burden of Disease
Study 2016. Lancet 2017; 390: 1260–344.
49 Dieleman J, Campbell M, Chapin A, et al. Evolution and patterns of
global health financing 1995–2014: development assistance for
health, and government, prepaid private, and out-of-pocket health
spending in 184 countries. Lancet 2017; 389: 1981–2004.
50 Mackenbach JP, Karanikolos M, Lopez Bernal J, Mckee M. Why did
life expectancy in Central and Eastern Europe suddenly improve in
the 1990s? An analysis by cause of death. Scand J Public Health 2015;
51 Shkolnikov VM, Andreev EM, McKee M, Leon DA. Components and
possible determinants of decrease in Russian mortality in 2004–2010.
Demogr Res 2013; 28: 917–50.
52 Cotlear D, Nagpal S, Smith OK, Tandon A, Cortez RA.
Going universal: how 24 developing countries are implementing
universal health coverage reforms from the bottom up.
Washington, DC: The World Bank, 2015.
53 Yu H. Universal health insurance coverage for 1·3 billion people:
What accounts for China’s success? Health Policy 2015; 119: 1145–52.
54 Atun R. Transforming Turkey’s health system—lessons for universal
coverage. N Engl J Med 2015; 373: 1285–89.
55 Shakya HS, Adhikari S, Gurung G, et al. Strengthening national
health systems for improving efficiency of health service delivery in
Nepal. J Nepal Health Res Counc 2012; 10: 101–07.
56 Lim J, Chan MMH, Alsagoff FZ, Ha D. Innovations in
non-communicable diseases management in ASEAN: a case
series. Glob Health Action 2014; 7: 25110.
57 Fullman N, Lozano R. Towards a meaningful measure of universal
health coverage for the next billion. Lancet Glob Health 2017;
58 Darmstadt GL, Bhutta ZA, Cousens S, Adam T, Walker N,
de Bernis L. Evidence-based, cost-effective interventions: how many
newborn babies can we save? Lancet 2005; 365: 977–88.
59 Beattie A, Yates R, Noble D. Accelerating progress toward universal
health coverage for women and children in South Asia, East Asia,
and the Pacific. New York: United Nations Children’s Fund, 2016.
60 Knaul FM, Farmer PE, Krakauer EL, et al. Alleviating the access abyss
in palliative care and pain relief—an imperative of universal health
coverage: the Lancet Commission report. Lancet 2017; 391: 1391–454.
61 Dieleman JL, Sadat N, Chang AY, et al. Trends in future health
financing and coverage: future health spending and universal health
coverage in 188 countries, 2016–40. Lancet 2018; 391: 1783–798.
62 Glassman A, Giedion U, Smith PC. What’s in what’s out? designing
benefits for universal health coverage. Washington, DC: Center for
Global Development, 2017.
63 Anselmi L, Lagarde M, Hanson K. Equity in the allocation of public
sector financial resources in low- and middle-income countries:
a systematic literature review. Health Policy Plan 2015; 30: 528–45.
64 Sadana R, Blas E, Budhwani S, Koller T, Paraje G. Healthy ageing:
raising awareness of inequalities, determinants, and what could be
done to improve health equity. Gerontologist 2016;
56 (suppl 2): S178–93.
65 WHO. World report on ageing and health 2015. Geneva: World
Health Organization, 2015.
66 Goodyear-Smith F, van Weel C. Account for primary health care
when indexing access and quality. Lancet 2017; 390: 205–06.
67 Weiss DJ, Nelson A, Gibson HS, et al. A global map of travel time to
cities to assess inequalities in accessibility in 2015. Nature 2018;